The chameleons many faces clinical spectrum, pathogenesis and therapy of lichen planus;Pleomorphismus des Lichen ruber klinische Variationsbreite, Pathogenese und Therapie

Aktuelle Dermatologie

Volumn 36, Issue 5, 2010, Pages 180-185

  Wolf, R ^a   Ruzicka, T ^a   Rupec, R A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 7; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYCLOSPORIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; KALININ; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; TACROLIMUS; THALIDOMIDE;

ALOPECIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LICHEN PLANUS; PATHOGENESIS; PROGNOSIS; PRURITUS; PUVA; REVIEW;

EID: 77951607273     PISSN: 03402541     EISSN: 1438938X     Source Type: Journal    
DOI: 10.1055/s-0029-1214947     Document Type: Review

References (28)

1. Boyd A S., Neldner K H. Lichen planus. J Am Acad Dermatol 1991 25 593-619
2. Mahood J M. Familial lichen planus. A report of nine cases from four families with a brief review of the literature. Arch Dermatol 1983 119 292-294
3. La Nasa G, Cottoni F, Mulargia M et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995 132 897-900
4. Vega M E., Waxtein L, Arenas R et al. Ashy dermatosis versus lichen planus pigmentosus: a controversial matter. Int J Dermatol 1992 31 87-88
5. Zillikens D, Caux F, Mascaro J M. et al. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999 113 117-121 (Pubitemid 29328169)
6. Kossard S, Lee M S., Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997 36 59-66 (Pubitemid 27043875)
7. Mehregan D A., Van Hale H M., Muller S A. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol 1992 27 935-942
8. Tosti A, Peluso A M., Fanti P A., Piraccini B M. Nail lichen planus: clinical and pathologic study of twenty-four patients. J Am Acad Dermatol 1993 28 724-730 (Pubitemid 23133382)
9. Silverman S Jr, Bahl S. Oral lichen planus update: clinical characteristics, treatment responses, and malignant transformation. Am J Dent 1997 10 259-263 (Pubitemid 127499545)
10. Setterfield J F., Neill S, Shirlaw P J. et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006 55 98-113 (Pubitemid 43867027)
11. Meller S, Gilliet M, Homey B. Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol 2009 129 315-319
12. Simark-Mattsson C, Bergenholtz G, Jontell M et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 1999 44 499-507 (Pubitemid 29264470)
13. Walton L J., Thornhill M H., Farthing P M. VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med 1994 23 262-268
14. Wenzel J, Tuting T. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in interface dermatitis. J Invest Dermatol 2008 128 2392-2402
15. Wayner E A., Gil S G., Murphy G F. et al. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 1993 121 1141-1152
16. Wenzel J, Peters B, Zahn S et al. Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol 2008 128 67-78 (Pubitemid 350249372)
17. Wenzel J, Wiechert A, Merkel C et al. IP10/CXCL10 CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus. Acta Derm Venereol 2007 87 112-117 (Pubitemid 46513195)
18. Yamamoto T, Nakane T, Osaki T. The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes. J Clin Immunol 2000 20 294-305 (Pubitemid 30619401)
19. Wolf R, Howard O M., Dong H F. et al. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 2008 181 1499-1506
20. Mignogna M D., Lo Muzio L, Lo Russo L et al. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol 2001 37 262-267 (Pubitemid 32245850)
21. Gandolfo S, Richiardi L, Carrozzo M et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 2004 40 77-83 (Pubitemid 37510216)
22. Hietanen J, Paasonen M R., Kuhlefelt M, Malmstrom M. A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. Oral Oncol 1999 35 278-282 (Pubitemid 29148361)
23. Duffey D C., Eversole L R., Abemayor E. Oral lichen planus and its association with squamous cell carcinoma: an update on pathogenesis and treatment implications. Laryngoscope 1996 106 357-362 (Pubitemid 126425682)
24. Turan H, Baskan E B., Tunali S et al. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol 2009 60 164-166
25. Gonzalez-Moles M A., Scully C, Gil-Montoya J A. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 2008 14 229-243 (Pubitemid 351379716)
26. Issa Y, Brunton P A., Glenny A M., Duxbury A J. Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 98 553-565 (Pubitemid 39505025)
27. Wackernagel A, Legat F J., Hofer A et al. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus. Photodermatol Photoimmunol Photomed 2007 23 15-19 (Pubitemid 46189301)
28. Taub A F. Photodynamic therapy: other uses. Dermatol Clin 2007 25 101-109